 Once they, it is discovered that this person is, for example, received the clinical diagnosis of Parkinson and that the actual procedure is appropriate for them, meaning that they're of good, you know, they're of good health otherwise that can handle a surgery like a coronatomy or a craniofacial, with the QE technology you're able to intervene at craniofacial intervention or surgical technique, the surgical thing that you can use because it's a small in size and you essentially use this passageway to insert a device about 1.9 by 2.2 millimeter in size, which is roughly about the grain of rice, into the zone that is being implicated. In the case of Parkinson that would be the sublimic nucleus or STN in the basal ganglia and you drive the Kiwi device chip into that area. It is then made of material carbon nanotubes that neurons start basically gathering around their area and growing. It would then sense this growth of neurons or the presence of these neurons start modulating electrophysiologically modulation pattern that is fit to stop the trimmer, which is the most immediate thing that we want to stop. So this neuromodulation happens by pulse generation essentially at a very very low power. There are two other therapeutic effects or engagement that takes place. One we refer to as a scaffolding effect and the second is or the third would be the up the genetics in the event that that's what we want to do which is re-growing cells or reprogramming the functional area in this projection zone. The system has the capability of communicating this data outside of the brain to a nearby device we refer to as a propagator and then the propagator is able to convey or connect this information to a system on the cloud that is essentially a full-scale referred to as a brain operating system that is capable of processing this data generating additional inferences or corrections or modification to the firmware or to the software and then following the same path for the backward again to back into the chip. That process continues on for the life of the therapy. We do inductively charging so that it's a chronic device we do not have to go back and take out unless there's some serious clinical malfunction or malfunction, electronic malfunction of the device which is all to be determined and worked out in the future tests before we actually go into the first patient with this full encapsulation.